Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. [[Lectin]]-like oxidized low-density [[lipoprotein]] receptor-1 ([[LOX-1]]), a member of the [[scavenger receptor]] family, recognizes multiple [[ligand]]s and participates in several [[inflammatory]] responses, but its function within the central nervous system (CNS) remains unclear. In a study, Ge et al., discovered an increased LOX-1 expression in activated [[microglia]] in vivo and in vitro. Employing the specific inhibitors, they found that conditioned medium of necrotic neurons (Necrotic-CM) induced microglial LOX-1 expression through the MAPKs/NF-κB pathway. Silencing LOX-1 inhibited MAPK phosphorylation, NF-κB-p65 nuclear transportation, and pro-inflammatory factor production in microglia exposed to Necrotic-CM. Furthermore, utilizing the conditioned medium of activated microglia (MG-CM), we discovered microglial LOX-1 aggravated the neuroinflammation-induced neuronal apoptosis. Collectively, a LOX-1/MPAKs/NF-κB positive loop might promote microglia activation and drive the vicious cycle of [[neuroinflammation]] and neuronal injury ((Ge X, Zhang DM, Li MM, Zhang Y, Zhu XY, Zhou Y, Peng X, Shen AG. Microglial LOX-1/MAPKs/NF-κB positive loop promotes the vicious cycle of neuroinflammation and neural injury. Int Immunopharmacol. 2019 Feb 23;70:187-200. doi: 10.1016/j.intimp.2019.02.013. [Epub ahead of print] PubMed PMID: 30807932. )). lox-1.txt Last modified: 2024/06/07 02:59by 127.0.0.1